Last updated on December 2019

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

Brief description of study

This research study is studying a possible therapy as a possible treatment for the consequences of Multiple Myeloma with renal insufficiency.

Detailed Study Description

This research study is a Phase II clinical trial. This study will assess the safety and tolerability of denosumab in Multiple Myeloma participants, by studying drug interactions with different parts of the body.

The FDA (the U.S. Food and Drug Administration) has not approved Denosumab for this specific disease but it has been approved denosumab for use in other cancers to treat cancer-related bone disease such as prostate and breast cancer.

Clinical Study Identifier: NCT02833610

Find a site near you

Start Over